Biden admin undoes Trump order on pricing for epipen, insulin

Daily WirePresident Joe Biden’s United States Department of Health and Human Services (HHS) on Thursday stopped executive orders from his predecessor designed to significantly lower prescription drug prices for Americans, including insulin and epinephrine.

Normally I'd call this situation something that shows the demand for market forces and competition in the market for those goods. But -- government regulation forms a tremendous barrier to entry in medical fields, and often patent laws do too. The result is an effective medical monopoly on goods people need for their health care (an artificial source of demand), combined with provably artificially inflated prices. This is why we have antitrust laws.

The price for an epipen was increased by a factor of over 100x prior to the Trump order. Just because the manufacturer decided to take some profits, not for any reasons relating to cost. That's exactly the sort of thing that should invite antitrust scrutiny.

And now the Biden admin is canceling those orders. But aren't the Democrats supposed to care about the cost of medical care to ordinary people?

I guess not anymore.

This entry was published Tue Jan 26 21:21:35 CST 2021 by TriggerFinger and last updated 2021-01-26 21:21:35.0. [Tweet]

comments powered by Disqus

Subscribe to Atom Feed

I am not a lawyer, and nothing on this site should be taken as legal advice.

This site is run on custom blog software and is being actively developed. Please be forgiving of errors.

This website is an Amazon affiliate and will receive financial compensation for products purchased from Amazon through links on this site.